Want to see CH:SKAN full AI Analyst Report?
SKAN Stock Chart & Stats
CHF54.50
CHF0.70(0.97%)
At close: 4:00 PM EST
CHF54.50
CHF0.70(0.97%)
Day’s Range― - ―
52-Week RangeCHF35.75 - CHF77.80
Previous CloseN/A
Volume1.93K
Average Volume (3M)22.50K
Market Cap
CHF1.25B
Enterprise ValueCHF1.15B
Total Cash (Recent Filing)CHF94.08M
Total Debt (Recent Filing)CHF131.47M
Price to Earnings (P/E)77.5
Beta0.98
Next Earnings
Aug 18, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield0.77%
Share Statistics
EPS (TTM)0.72
Shares Outstanding22,483,524
10 Day Avg. Volume19,367
30 Day Avg. Volume22,504
Financial Highlights & Ratios
PEG Ratio-1.26
Price to Book (P/B)10.37
Price to Sales (P/S)3.56
P/FCF Ratio56.51
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)1.36
Revenue Forecast (FY)CHF392.90M
Bulls Say, Bears Say
Bulls Say
Revenue Recovery & Durable DemandA sharp 36% revenue rebound in 2025 signals renewed ordering from pharmaceutical and biotech customers and successful execution on large projects. Durable demand for contamination-control systems supports backlog buildup and recurring services, underpinning revenue visibility over the next 2–6 months.
High Gross MarginsSustained gross margins near 69–74% reflect a strong product and service mix with engineering value-add. High margins provide structural insulation versus revenue cyclicality, preserving contribution to operating income and enabling reinvestment in R&D and lifecycle service capabilities over the medium term.
Improved Cash Generation In 2025Operating cash flow rising to ~64m and positive free cash flow (~21m) in 2025 demonstrates the company's ability to convert project deliveries into cash. This strengthens capacity to fund aftermarket services, targeted capex and deleveraging, improving financial flexibility if maintained beyond one year.
Bears Say
Rising LeverageDebt-to-equity increasing to ~1.15 after years of low leverage materially reduces balance-sheet flexibility. Higher leverage raises interest and refinancing risk, limits ability to pursue strategic investments, and increases vulnerability to any sustained margin or revenue weakness in the coming quarters.
Weakened Profitability And Margin VolatilityOperating and net margins halved in 2025 versus 2024, showing meaningful margin erosion. Persistent margin weakness or continued volatility reduces free cash generation, makes debt servicing harder, and signals sensitivity to project mix, pricing or rising costs—posing a structural headwind over months.
Inconsistent Free Cash Flow ConversionVolatile free cash flow and FCF covering only ~33% of net income in 2025 indicate earnings do not reliably convert to cash. Weak conversion limits internal funding for capex, service expansion and debt reduction, elevating refinancing and liquidity risk if favorable cash years do not persist.
SKAN Group AG News
SKAN FAQ
What was SKAN Group AG’s price range in the past 12 months?
SKAN Group AG lowest stock price was CHF35.75 and its highest was CHF77.80 in the past 12 months.
What is SKAN Group AG’s market cap?
SKAN Group AG’s market cap is CHF1.25B.
When is SKAN Group AG’s upcoming earnings report date?
SKAN Group AG’s upcoming earnings report date is Aug 18, 2026 which is in 46 days.
How were SKAN Group AG’s earnings last quarter?
SKAN Group AG released its earnings results on Mar 24, 2026. The company reported CHF1.12 earnings per share for the quarter, beating the consensus estimate of CHF1 by CHF0.12.
Is SKAN Group AG overvalued?
According to Wall Street analysts SKAN Group AG’s price is currently Overvalued.
Does SKAN Group AG pay dividends?
SKAN Group AG pays a Annually dividend of CHF0.22 which represents an annual dividend yield of 0.77%. See more information on SKAN Group AG dividends here
What is SKAN Group AG’s EPS estimate?
SKAN Group AG’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does SKAN Group AG have?
SKAN Group AG has 22,483,524 shares outstanding.
What happened to SKAN Group AG’s price movement after its last earnings report?
SKAN Group AG reported an EPS of CHF1.12 in its last earnings report, beating expectations of CHF1. Following the earnings report the stock price went down -3.535%.
Which hedge fund is a major shareholder of SKAN Group AG?
Currently, no hedge funds are holding shares in CH:SKAN
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
SKAN Group AG
SKAN Group AG is a global leader specializing in critical solutions for the pharmaceutical and chemical sectors, offering advanced isolators, cleanroom technologies, and decontamination processes across Asia, Europe, and the Americas. The company operates through two distinct divisions: Equipment and Solutions (E&S), and Services and Consumables (S&C). Its E&S segment delivers essential products for pharmaceutical manufacturing, including high-tech isolators, integrated automated systems, aseptic filling solutions, and specialized laboratory and cleanroom equipment. Meanwhile, the S&C segment focuses on providing comprehensive life cycle support, ready-to-use consumables, and custom digital and client-specific solutions. Founded in 1968, the company, which changed its name from BV Holding AG to SKAN Group AG in October 2021, is headquartered in Allschwil, Switzerland.
Technical Analysis
SFS Group AG
―
Straumann Holding AG
―
Tecan Group AG
―
Ypsomed Holding AG
―
COMET Holding AG
―
Options Prices
Currently, No data available
---